Endospan, a pioneer in off-the-shelf EndoVascular Aortic Repair (EVAR), announced today that it has received CE marking for its HORIZON Stent Graft System to treat Abdominal Aortic Aneurysm (AAA).

CEO, Kevin Mayberry of Endospan commented, “HORIZON is a unique platform that can be used in a 14Fr single-sided approach, generally shortening and simplifying EVAR procedures.” He added, “HORIZON is supported by a strong cohort of pivotal trial data with over three years of follow-up to support the commercialization effort.

“We are very proud to have earned CE mark in a challenging regulatory environment. Now, with CE mark in hand, we are looking forward to working with potential partners to commercialize the HORIZON system for AAA repair,” added Mayberry.